General MedicationsORALGeneric

AUGMENTIN '125'

AMOXICILLIN; CLAVULANATE POTASSIUM

Standard Dose

125MG;EQ 31.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview AUGMENTIN '125' is listed in Drugs@FDA under application 050597 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMOXICILLIN; CLAVULANATE POTASSIUM Form and strength TABLET, CHEWABLE;ORAL - 125MG;EQ 31.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor US ANTIBIOTICS Submission history Latest submission status date: 2024-05-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview AUGMENTIN '125' is listed in Drugs@FDA under application 050597 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMOXICILLIN; CLAVULANATE POTASSIUM Form and strength TABLET, CHEWABLE;ORAL - 125MG;EQ 31.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor US ANTIBIOTICS Submission history Latest submission status date: 2024-05-01 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.